CompletedNot Applicable

Co-producing a Novel Model an Outcome Framework for the Implementation of Falls Management in Care Home Settings.

United Kingdom31 participantsStarted 2023-03-02

Plain-language summary

AIM: To co-produce a novel model for implementation of falls management for older people living in care homes SECONDARY OBJECTIVES Component One Objectives: Primary :To co-produce a novel model for the implementation of falls management in care homes Secondary * To facilitate a series of co-production workshops with representation of key stakeholders * To co-produce a novel implementation model for falls management * To co-produce an outcomes framework to evaluate the implementation model * To explore the feasibility of delivering the model and using the outcomes framework across Nottingham and Nottinghamshire Integrated Care Systems (ICSs) Component Two Objectives: * To evaluate how and the extent to which co-production occurs during the process of developing a novel model and an outcomes framework for the implementation for falls management in care homes * To reflect on challenges and facilitators of using co-production approaches in this context * To evaluate how care home residents can be supported to voice their priorities within the process.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Key stakeholders within an ICS system including: carers, registered health professionals, managers and owners/executives from care homes commissioners, health care professionals and regulators involved in care home and falls management pathways, residents living in care homes relatives of residents living in care homes * 18 years and over (no upper age limit) * Any member of staff working in the 10 case study care homes in Nottinghamshire Exclusion Criteria: * Unable to read and understand written English * Lack of capacity to give informed consent

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Key features of the falls management implementation model and outcomes framework using thematic analysis from the co-design workshops through study completion anticipated at 18 months

Timeframe: From enrolment to the end of the co-design workshops at 12 months

Trial details

NCT IDNCT06947915

SponsorUniversity of Nottingham

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-18

View on ClinicalTrials.gov More Old Age trials